Please allow me to introduce myself. I am MD of Biovalys who will market Albumin in Thailand. I would take this opportunity to clarify that this is normal case for the registration issue since Thailand follow the ACTD. Furthermore, registration in Thailand need no any clinical study comparing to VN or even Korea. Market opportunity is huge so far for Albumin. Thus would you please elaborate to them and notice them that export market now is growing every company need to expand and off course with expertise partner. I believe that you can well communicate to them since BVL also act as an agent for lot of suppliers thus I do well understand on your situation.
BTW, what is the TP to us since I never been informed regarding the TP. Please advise so that I can decide also. Many thanks.